دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Percutaneous Implantation of Adult Sized Stents for Coarctation of the Aorta in Children ?20 kg
Brian A. Boe, Aimee K. Armstrong, Sarah A. Janse, Eméfah C. Loccoh, Katie Stockmaster, Ralf J. Holzer, Sharon L. Cheatham, John P. Cheatham, Darren P. Berman
doi : 10.1161/CIRCINTERVENTIONS.120.009399
Circulation: Cardiovascular Interventions. 2021;14:e009399
Stent implantation (SI) is more effective than balloon angioplasty for the treatment of coarctation of the aorta (CoA). Due to technical factors, balloon angioplasty is more commonly performed in small patients. We sought to evaluate outcomes of percutaneous adult sized SI for the treatment of CoA in small patients.
Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial
Kenji Kanenawa, Kyohei Yamaji, Hiroaki Tashiro, Takenori Domei, Kenji Ando, Hirotoshi Watanabe, Takeshi Kimura
doi : 10.1161/CIRCINTERVENTIONS.120.010007
Circulation: Cardiovascular Interventions. 2021;14:e010007
We sought to evaluate the impact of patient selection for the STOPDAPT-2 trial (Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2) on clinical outcomes in a registry from a single center that participated in the STOPDAPT-2 trial.
Relative Impact of Clinical Risk Versus Procedural Risk on Clinical Outcomes After Percutaneous Coronary Intervention
Jeehoon Kang, Kyung Woo Park, Hak Seung Lee, Chengbin Zheng, Tae-Min Rhee, You-Jeong Ki, Mineok Chang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Bon-Kwon Koo, Hyo-Soo Kim
doi : 10.1161/CIRCINTERVENTIONS.120.009642
Circulation: Cardiovascular Interventions. 2021;14:e009642
The clinical outcome after percutaneous coronary intervention (PCI) is affected by various clinical and procedural risk factors. We investigated the relative impact of clinical and procedural risks on clinical outcomes after PCI.
Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction
Bj?rn Redfors, Reza Mohebi, Gennaro Giustino, Shmuel Chen, Harry P. Selker, Holger Thiele, Manesh R. Patel, James E. Udelson, E. Magnus Ohman, Ingo Eitel, Christopher B. Granger, Akiko Maehara, Ziad A. Ali, Ori Ben-Yehuda, Gregg W. Stone
doi : 10.1161/CIRCINTERVENTIONS.120.009879
Circulation: Cardiovascular Interventions. 2021;14:e009879
Symptom-to-balloon time (SBT) and door-to-balloon time (DBT) are both considered important metrics in patients undergoing primary percutaneous coronary intervention (pPCI) for ST-segment–elevation myocardial infarction (STEMI). We sought to assess the relationship of SBT and DBT with infarct size and microvascular obstruction (MVO) after pPCI.
Time to Reperfusion in ST-Segment Elevation Acute Myocardial Infarction
Karthik Murugiah, Aakriti Gupta, Harlan M. Krumholz
doi : 10.1161/CIRCINTERVENTIONS.121.010459
Circulation: Cardiovascular Interventions. 2021;14:e010459
Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial Infarction
Annette M. Maznyczka, Peter J. McCartney, Keith G. Oldroyd, Mitchell Lindsay, Margaret McEntegart, Hany Eteiba, J. Paul Rocchiccioli, Richard Good, Aadil Shaukat, Keith Robertson, Christopher J. Malkin, John P. Greenwood, James M. Cotton, Stuart Hood, Stuart Watkins, Damien Collison, Lynsey Gillespie, Thomas J. Ford, Robin A.P. Weir, Alex McConnachie, Colin Berry
doi : 10.1161/CIRCINTERVENTIONS.120.009529
Circulation: Cardiovascular Interventions. 2021;14:e009529
The index of microcirculatory resistance (IMR) of the infarct-related artery and left ventricular end-diastolic pressure (LVEDP) are acute, prognostic biomarkers in patients undergoing primary percutaneous coronary intervention. The clinical significance of IMR and LVEDP in combination is unknown.
Accuracy of Intravascular Ultrasound-Based Fractional Flow Reserve in Identifying Hemodynamic Significance of Coronary Stenosis
Wei Yu, Toru Tanigaki, Daixin Ding, Peng Wu, Haiyan Du, Li Ling, Biao Huang, Guanyu Li, Wei Yang, Su Zhang, Fuhua Yan, Munenori Okubo, Bo Xu, Hitoshi Matsuo, William Wijns, Shengxian Tu
doi : 10.1161/CIRCINTERVENTIONS.120.009840
Circulation: Cardiovascular Interventions. 2021;14:e009840
Ultrasonic flow ratio (UFR) is a novel method for fast computation of fractional flow reserve (FFR) from intravascular ultrasound images. The objective of this study is to evaluate the diagnostic performance of UFR using wire-based FFR as the reference.
Transcatheter Tricuspid Valve Intervention in Patients With Right Ventricular Dysfunction or Pulmonary Hypertension
Guillem Muntané-Carol, Maurizio Taramasso, Mizuki Miura, Mara Gavazzoni, Alberto Pozzoli, Hannes Alessandrini, Azeem Latib, Adrian Attinger-Toller, Luigi Biasco, Daniel Braun, Eric Brochet, Kim A. Connelly, Sabine de Bruijn, Paolo Denti, Florian Deuschl, Edith Lubos, Sebastian Ludwig, Daniel Kalbacher, Rodrigo Estevez-Loureiro, Neil Fam, Christian Frerker, Edwin Ho, Jean-Michel Juliard, Ryan Kaple, Susheel Kodali, Felix Kreidel, Claudia Harr, Alexander Lauten, Julia Lurz, Vanessa Monivas, Michael Mehr, Tamin Nazif, Georg Nickening, Giovanni Pedrazzini, François Philippon, Fabien Praz, Rishi Puri, Ulrich Sch?fer, Joachim Schofer, Horst Sievert, Gilbert H.L. Tang, Ahmed A. Khattab, Martin Andreas, Marco Russo, Holger Thiele, Matthias Unterhuber, Dominique Himbert, Marina Urena, Ralph Stephan von Bardeleben, John G. Webb, Marcel Weber, Stephan Windecker, Mirjam Winkel, Michel Zuber, J?rg Hausleiter, Philipp Lurz, Francesco Maisano, Martin B. Leon, Rebecca T. Hahn, Josep Rodés-Cabau See fewer authors
doi : 10.1161/CIRCINTERVENTIONS.120.009685
Circulation: Cardiovascular Interventions. 2021;14:e009685
Scarce data exist on patients with right ventricular dysfunction (RVD) or pulmonary hypertension (PH) undergoing transcatheter tricuspid valve intervention. This study aimed to determine the early and midterm outcomes and the factors associated with mortality in this group of patients.
Transcatheter Tricuspid Valve Intervention in Right Ventricular Dysfunction and Pulmonary Hypertension
Carey Kimmelstiel, Charles D. Resor
doi : 10.1161/CIRCINTERVENTIONS.121.010482
Circulation: Cardiovascular Interventions. 2021;14:e010482
Prognostic Impact of Change in Nutritional Risk on Mortality and Heart Failure After Transcatheter Aortic Valve Replacement
Roc?o Gonz?lez Ferreiro, Diego L?pez Otero, Leyre ?lvarez Rodr?guez, ?scar Otero Garc?a, Marta Pérez Poza, Pablo José Ant?nez Mui?os, Carla Cacho Antonio, Javier L?pez Pais, M?ria Juskowa, Ana Belén Cid ?lvarez, Ramiro Trillo Nouche, Xoan Carlos Sanmart?n Pena, Pedro Luis S?nchez Fern?ndez, Ignacio Cruz-Gonz?lez, José Ram?n Gonz?lez Juanatey
doi : 10.1161/CIRCINTERVENTIONS.120.009342
Circulation: Cardiovascular Interventions. 2021;14:e009342
Limited data are available regarding change in the nutritional status after transcatheter aortic valve replacement (TAVR). This study evaluated the prognostic impact of the change in the geriatric nutritional risk index following TAVR.
Malnutrition and Transcatheter Aortic Valve Replacement
Paul Ohayon, Anita W. Asgar
doi : 10.1161/CIRCINTERVENTIONS.121.010483
Circulation: Cardiovascular Interventions. 2021;14:e010483
Short-Term Outcomes of Transcatheter Versus Isolated Surgical Aortic Valve Replacement for Mediastinal Radiation-Associated Severe Aortic Stenosis
Victor Nauffal, Camden Bay, Pinak B. Shah, Piotr S. Sobieszczyk, Tsuyoshi Kaneko, Patrick O’Gara, Anju Nohria
doi : 10.1161/CIRCINTERVENTIONS.120.010009
Circulation: Cardiovascular Interventions. 2021;14:e010009
Surgical aortic valve replacement (SAVR) is associated with adverse outcomes in patients with radiation-associated aortic stenosis. Transcatheter aortic valve replacement (TAVR) may improve outcomes in this population.
Therapeutic Approaches for the No-Option Refractory Angina Patient
Thomas J. Povsic, Timothy D. Henry, E. Magnus Ohman
doi : 10.1161/CIRCINTERVENTIONS.120.009002
Circulation: Cardiovascular Interventions. 2021;14:e009002
The combination of an aging population and improved survival rates among patients with coronary artery disease has resulted in an increase in the number of patients with refractory angina or anginal equivalent symptoms despite maximal medical therapy. Patients with refractory angina are often referred to the cardiac catheterization laboratory; however, they have often exhausted conventional revascularization options; thus, this population is often deemed as having “no options.” We review the definition, prevalence, outcomes, therapeutic options, and treatment considerations for no-option refractory angina patients and focus on novel therapies for this complex and challenging population. We propose a multidisciplinary team approach for the evaluation and management of patients with refractory angina, ideally in a designated clinic. The severe limitations and symptomatology experienced by these patients highlight the need for additional research into the development of innovative treatments.
Percutaneous Coronary Intervention Without Interruption of Oral Anticoagulation
Juan G. C?rdoba-Soriano, Juan Francisco Oteo, Antonio Gutiérrez-D?ez, Andrés Escudero-D?az, Arsenio Gallardo-L?pez, Juan José Portero-Portaz, Pablo Salinas, Elena Pérez-Pereira, Driss Melehi, Jes?s Jiménez-Mazuecos
doi : 10.1161/CIRCINTERVENTIONS.120.009949
Circulation: Cardiovascular Interventions. 2021;14:e009949
Risk Factors and Outcomes of Postprocedure Complete Left Bundle Branch Block After Transcatheter Device Closure of Perimembranous Ventricular Septal Defect
Diandong Jiang, Youfei Fan, Bo Han, Lijian Zhao, Yingchun Yi, Jianjun Zhang, Jianli Lv, Jing Wang
doi : 10.1161/CIRCINTERVENTIONS.120.009823
Circulation: Cardiovascular Interventions. 2021;14:e009823
2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
Mark A. Creager, Naomi M. Hamburg, Keith D. Calligaro, Ana I. Casanegra, Rosario Freeman, Phyllis A. Gordon, Heather L. Gornik, Esther S.H. Kim, Nicholas J. Leeper, Geno J. Merli, Khusrow Niazi, Jeffrey W. Olin, Rene Quiroz, Elona Rrapo Kaso, Suman Wasan, Andrew R. Waxler, Christopher J. White, Khendi White Solaru, Marlene S. Williams
doi : 10.1161/HCV.0000000000000079
Circulation: Cardiovascular Interventions. 2021;14:e000079
Correction to: 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions): A Report of the ACC Competency Management Committee
doi : 10.1161/HCV.0000000000000082
Circulation: Cardiovascular Interventions. 2021;14:e000082
